Approximately, more than 14 million Americans are estimated to have active symptoms of coronary artery disease. However, in order to control the inclining death rates caused by heart diseases, major companies in medical device industry have been developing a number of exclusive interventional devices to revive the patients’ heart conditions. Out of the coronary and peripheral interventional devices, coronary stents have emerged as an innovative treatment for a person suffering from coronary artery disease in the last decade. Coronary stents provide a path to the blood flow in the blocked coronary arteries in patients suffering from the condition of coronary restenosis.

Recent advancements in coronary stent technology have caused a considerable number of ups and downs in the coronary stent market’s growth trajectory. The arrival of technologically advanced stent designs has led to obsolescence of conventional stents such as bare mental stents. This paradigm shift in patients’ changing preferences of stents has hugely affected the coronary stent market revenues in the country. In order to provide treatments to the growing number of cardiac arrests amongst the US citizens, leading global players in the stent manufacturing business have formulated types of new material for manufacturing coronary stents, developing new drug-coating techniques and implementing a number of new stent surface technologies.

The coronary stent market in the US is majorly occupied by four leading players namely Abbott Laboratories, Johnson and Johnson, Medtronic and Boston Scientific Inc. Johnson and Johnson Inc, which operated through its flagship brand named Cordis in the stent market, decided to make an exit from the coronary stent business in 2012. Owing to the higher price range of stents as compared to other alternative methods that are available to cure coronary artery disease, the coronary stent market in the US has been adversely affected in the last few years. Additionally, the increasing numbers of delayed thrombosis cases and other coronary complications after stent implantations have also hampered the market’s performance over the past few years.

According to the research report, The US Coronary Stent Industry Outlook to 2018 - Bioabsorbable Stents to Drive the Future Growth by Ken Research, the contribution of drug eluting and bare metal stents is likely to decrease in the overall coronary stents market, which will be replaced by latest polymer based bio-absorbable stents in the coming years.

“The growing incidences of cardiac diseases in the country coupled with inclining ageing population will impel the demand of PCI procedure, which will increase the demand of coronary stents in the US”, according to the Research Analyst, Ken Research.

The report provides detailed overview on the coronary stent market and helps readers to identify the ongoing trends in the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report will help industry consultants, healthcare experts, medical device manufacturers and suppliers and other stakeholders align their market centric strategies according to ongoing and expected trends in future.



[b]Read More:[/b]

http://www.kenresearch.com/healthcare/medical-devices-and-equipments/us-coronary-stent-market-research-report/465-91.html

[b]Contact Person: Ankur Gupta[/b]

[b]E-mail: [email protected][/b]